43
Participants
Start Date
September 30, 2007
Primary Completion Date
June 30, 2011
Study Completion Date
February 28, 2015
Bevacizumab
Bevacizumab 4 cycles each 15 days, the first 10 mg/kg and the rest of cycles with 5 mg/kg.
capecitabine (Xeloda)
Capecitabine 900 mg/m2 two times a day concomitant during radiotherapy period
Rectal Radiotherapy
Radiotherapy in rectum 45 Gy starting on Bevacizumab 2nd cycle during 5 weeks, 1.8 Gy per day, 5 days at week.
Institut Català d'Oncologia-L'Hospitalet, L'Hospitalet Del Llobregat
Hoffmann-La Roche
INDUSTRY
Institut Català d'Oncologia
OTHER